In the new workshop, called the Healthcare Innovation & Commercialization (HIC) Course, students will learn about industry trends, regulatory and reimbursement issues, venture capital, finance, licensing and other matters related to healthcare and life science entrepreneurship. The workshops start on Thursday, September 15, with a session from 4:30–6:30 p.m.
Courses will be instructed by thought leaders in the biotech and medtech industries:
- Mark Namchuk, Head of Cambridge Research, Vertex Pharmaceuticals
- John Brooks, President and CEO of Joslin Diabetes Center and founder of Prism VentureWorks and Insulet
- Anupendra Sharma, Partner at Siemens Venture Capital
- And many more...
This class is eligible for PATHs nanocourse credit for Division of Medical Sciences students.
FREE Gourmet dinner and dessert plus networking with speakers will follow each session.
Course Dates: Thursday evenings, September 15 to November 17, from 4:30–6:30 p.m., followed by dinner and networking with speakers
Class will be limited to 60 students.
For more information please see the website.
Click here to register.
This email address is being protected from spambots. You need JavaScript enabled to view it.
with questions.
HIC is sponsored by Goodwin Procter LLP and the Division of Medical Sciences.